Q2 2025 Thermo Fisher Scientific Inc Earnings Call Transcript
Key Points
- Thermo Fisher Scientific Inc (TMO) delivered excellent operational performance in Q2 2025, with revenue growing 3% to $10.85 billion, surpassing guidance.
- The company launched several innovative products, including next-generation Thermo Scientific Orbitrap mass spectrometers and the Thermo Scientific Krios 5 Cryo transmission electron microscope, receiving positive customer feedback.
- Thermo Fisher Scientific Inc (TMO) increased its full-year guidance for 2025, expecting revenue between $43.6 billion and $44.2 billion and adjusted EPS between $22.22 and $22.84.
- The company is actively managing its cost base, adding $300 million in cost reductions for 2025, and leveraging its PPI Business System to enhance productivity and reduce costs.
- Thermo Fisher Scientific Inc (TMO) is expanding its strategic partnership with Sanofi, acquiring a sterile fill-finish site in New Jersey to meet growing demand for US manufacturing capacity.
- Revenue in the academic and government segment declined mid-single digits in Q2 2025 due to customer hesitancy in an uncertain environment.
- The Analytical Instruments segment experienced a 4% decline in organic growth, impacted by tariffs and muted demand for equipment and instrumentation.
- Revenue in the diagnostics and healthcare segment declined in the low single digits, facing headwinds in China.
- The company is navigating a challenging macro environment, including US-China tariffs, which have impacted adjusted operating income and margins.
- Thermo Fisher Scientific Inc (TMO) anticipates continued headwinds in the academic and government funding environment, impacting demand in the second half of 2025.
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 second-quarter conference call.
(Operator Instructions) I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations.
Mr. Tejada, you may begin the call.
Good morning and thank you for joining us.
On the call with me today is Marc Casper, our Chairman, President, and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the ambassador section of our website, thermofisher.com under the heading News, Events & Presentations until October 21, 2025. A copy of the press release of our second-quarter earnings is available in the Investor section of our website under the heading, Financials
So, before we begin, let me briefly cover our Safe Harbor Statement. Various remarks that we may make about the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
